Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Bioanalysis
|
March 28, 2023
Non-regulated LC-MS/MS bioanalysis in support of early drug development: a Novartis perspective
Yunlin Fu, Wenkui Li, Franck Picard
Bioanalysis
|
September 26, 2024
Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis
Wenkui Li, Yunlin Fu, Franck Picard
Bioanalysis
|
May 1, 2020
Evaluation, identification and impact assessment of abnormal internal standard response variability in regulated LC-MS bioanalysis
Yunlin Fu, Deborah Barkley, Wenkui Li, et al.
Bioanalysis
|
March 2, 2022
Sensitive LC-MS/MS quantification of unconjugated maytansinoid DM4 and its metabolite S-methyl-DM4 in human plasma
Yunlin Fu, Shashank Gorityala, Wenkui Li, et al.
Bioanalysis
|
May 7, 2011
An investigation of incurred human urine sample reanalysis failure
Yunlin Fu, Wenkui Li, Harold T Smith, et al.
Bioanalysis
|
June 3, 2021
An integrated outsourcing practice of nonclinical LC-MS bioanalysis and toxicokinetics at Novartis small molecule drug development
Wenkui Li, Jim Glick, Panos Hatsis, et al.
Bioanalysis
|
December 24, 2010
Capsule review on bioanalytical method transfer: opportunities and challenges for chromatographic methods
Zhongping John Lin, Wenkui Li, Naidong Weng
Bioanalysis
|
April 21, 2016
Quantitative analysis of hIgG1 in monkey serum by LC-MS/MS using mass spectrometric immunoassay
Christian Lanshoeft, Olivier Heudi, Sarah Cianférani, et al.
Bioanalysis
|
March 10, 2015
Ultrafast quantitative MS-based method for ceritinib analysis in human plasma samples from clinical trial
Christian Lanshoeft, Olivier Heudi, Marc Raccuglia, et al.
Bioanalysis
|
October 16, 2020
Dixon's Q-test and Student's t-test to assess analog internal standard response in nonregulated LC-MS/MS bioanalysis
Deborah Barkley, Panos Hatsis, Jim Glick, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Bioanalysis
|
March 28, 2023
Non-regulated LC-MS/MS bioanalysis in support of early drug development: a Novartis perspective
Yunlin Fu, Wenkui Li, Franck Picard
Bioanalysis
|
September 26, 2024
Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis
Wenkui Li, Yunlin Fu, Franck Picard
Bioanalysis
|
May 1, 2020
Evaluation, identification and impact assessment of abnormal internal standard response variability in regulated LC-MS bioanalysis
Yunlin Fu, Deborah Barkley, Wenkui Li, et al.
Bioanalysis
|
March 2, 2022
Sensitive LC-MS/MS quantification of unconjugated maytansinoid DM4 and its metabolite S-methyl-DM4 in human plasma
Yunlin Fu, Shashank Gorityala, Wenkui Li, et al.
Bioanalysis
|
May 7, 2011
An investigation of incurred human urine sample reanalysis failure
Yunlin Fu, Wenkui Li, Harold T Smith, et al.
Bioanalysis
|
June 3, 2021
An integrated outsourcing practice of nonclinical LC-MS bioanalysis and toxicokinetics at Novartis small molecule drug development
Wenkui Li, Jim Glick, Panos Hatsis, et al.
Bioanalysis
|
December 24, 2010
Capsule review on bioanalytical method transfer: opportunities and challenges for chromatographic methods
Zhongping John Lin, Wenkui Li, Naidong Weng
Bioanalysis
|
April 21, 2016
Quantitative analysis of hIgG1 in monkey serum by LC-MS/MS using mass spectrometric immunoassay
Christian Lanshoeft, Olivier Heudi, Sarah Cianférani, et al.
Bioanalysis
|
March 10, 2015
Ultrafast quantitative MS-based method for ceritinib analysis in human plasma samples from clinical trial
Christian Lanshoeft, Olivier Heudi, Marc Raccuglia, et al.
Bioanalysis
|
October 16, 2020
Dixon's Q-test and Student's t-test to assess analog internal standard response in nonregulated LC-MS/MS bioanalysis
Deborah Barkley, Panos Hatsis, Jim Glick, et al.
Page
of 3